Live Quote · NASDAQCBIOHealthcare· Biotechnology

Crescent Biopharma, Inc.

$13.00▲ 0.70%(+$0.09)
MKT CAP $505.64MNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
56/100
▌ Mixed
67
Valuation
40
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBIO research report →

Analyst Price Target
$36.00+176.9% vs. today

Range $36 – $36

Analyst RatingBuy
10 Buy4 Hold0 Sell

Price Chart

-0.61% · this period
$26.98$17.96$8.94Nov 20May 26Nov 20
52-Week Range23% of range
Low
$8.72
Current
$13.00
High
$27.41